The 34th Seoul Music Awards lit up the Inspire Arena in South Korea tonight, celebrating the biggest names in K-pop and Korean music from January 2024 to March 2025.
Hosted by Kang Seung-yoon, Miyeon of (G)I-DLE, and Soobin of TXT, the star-studded event honored the past year’s best music across multiple categories. Young Tak was the night’s biggest winner, taking home four awards, including major honors in the trot and popularity categories. Tomorrow X Together (TXT) and Doyoung each won three awards. Rosé of BLACKPINK and rising rookie group NCT Wish each earned two awards. See the full list of winners below.
Related
Grand Prize (Daesang)
• (G)I-dle — WINNER
Main Prize (Bonsang)
• Aespa
• Doyoung
• Enhypen
• G-Dragon
• (G)I-dle
• Ive
• NCT Dream
• NCT Wish
• P1Harmony
• QWER
• Rosé
• Seventeen
• Stray Kids
• Tomorrow X Together
• Young Tak
• Zerobaseone
Rookie of the Year
• Hearts2Hearts — WINNER
• KickFlip
• KiKiLiLi
• 3Piece
• ARIC
• Blingee
• Dignity
• Loved
• MaeDon
• Noveah
• Outland
• Riize
• Say My Name
Best Song Award
• Tomorrow X Together – “Deja Vu” — WINNER
Best Album Award
• Tomorrow X Together – Minisode 3: Tomorrow — WINNER
• Zerobaseone – Blue Paradise — WINNER
Ballad Award
• Hwang Karam – “I’m Firefly” — WINNER
R&B / Hip-hop Award
• RM – “Lost!” — WINNER
Rising Star Award
• VVUP — WINNER
• 82Major
• Envie
• Fantasy Boys
• Lune
• The Pact
• Pow
• Chantel
• TNX
• Young Posse
• Popularity Award: Lee Chan-won — WINNER
• K-Wave Special Award: Jimin — WINNER
• K-pop World Choice – Group: Babymonster — WINNER
• K-pop World Choice – Solo: Young Tak — WINNER
Special Awards
Best Group Award:
• Illit — WINNER
• NCT Wish — WINNER
Best Performance Award:
• Cravity — WINNER
• Fifty Fifty — WINNER
• Best Solo Award: Doyoung — WINNER
• Best Band Award: Wave to Earth — WINNER
• K-pop Special Award: BtoB — WINNER
• Discovery of the Year: Say My Name — WINNER
World Best Artist:
• Aespa — WINNER
• Rosé — WINNER
OST Award
• Young Tak – “Unpredictable Life” (from Eagle Brothers) — WINNER
Trot Award
• Young Tak — WINNER






Leave a Reply